The neurology billing partner in Texas that protects your most valuable revenue streams is one built for four high-value areas. These are Novitas Solutions LCD-compliant neurodiagnostic coding, EEG and EMG documentation that survives Medicare Advantage algorithmic review, high-complexity E/M audit defense, and infusion therapy prior authorization management. In fact, these are the four revenue categories where generic medical billing services in Texas consistently fail.
According to AAN benchmarking data, top-performing neurology practices collect 94%–97% of collectible revenue. However, the specialty average sits 9%–13% below that threshold. As a result, each physician group loses $400,000–$900,000 in preventable revenue leakage every 12 months.
Key Takeaways
- The right neurology billing partner in Texas protects four revenue streams. These are Novitas LCD-compliant neurodiagnostics (EEG, EMG, NCS), Medicare Advantage diagnostic reads, high-complexity E/M (99215), and MS biologic infusion billing.
- Top neurology practices collect 94%–97% of collectible revenue. By contrast, the specialty average is 9%–13% lower. For one physician group, that gap can mean $400,000–$900,000 in lost revenue each year.
- Texas also adds unique pressure. For example, it has above-average Medicare Advantage use, STAR/STAR+PLUS prior authorizations, and strict Novitas LCD enforcement.
- New for 2026, the CMS WISeR Model adds prior authorization to select Original Medicare services in Texas. In addition, a new CMS rule sets faster prior authorization deadlines for MA and Medicaid managed care plans.
- MBC prevents denials before submission and starts with a free 90-Day AR Diagnostic. The goal is a 93%–97% net collection ratio, a 3%–5% denial rate, and 18–24 days in AR.
Which neurology billing partner in Texas protects your most valuable revenue streams? The best choice is a specialty-focused partner that prevents denials before submission instead of appealing them later. First, look for Novitas LCD expertise for EEG, EMG, and NCS. Next, check for Medicare Advantage audit defense and E/M MDM coaching for 99215 capture. Also, confirm accurate infusion billing (J2323, J2350, J3061) and Texas STAR/STAR+PLUS authorization support. Finally, make sure the partner is ready for 2026 prior authorization changes such as the CMS WISeR Model. Medical Billers and Coders (MBC) offers all of these. Moreover, it works on a percentage-of-collections model with no upfront cost.
Why Texas Makes Neurology Billing Harder Than Most States
Texas presents a uniquely complex neurology billing environment. Three payer pressures compound one another, and generalist RCM vendors are not built to manage them.
First, Medicare Advantage penetration in Texas exceeds the national average across Houston, Dallas-Fort Worth, San Antonio, and Austin. This means a large share of Texas neurology claims flow through MA plans. These plans use NLP-based algorithmic review to auto-downcode diagnostic interpretations. As a result, they deny these claims at 2.4 times the traditional Medicare rate.
Second, Texas Medicaid managed care runs through STAR and STAR+PLUS. These programs require prior authorization for neurodiagnostic procedures, infusion therapies, and specialist referrals. Without dedicated authorization workflows, groups face AR Aging cycles of 50–80 days. Third, Texas neurology practices fall under Novitas Solutions MAC jurisdiction. Novitas enforces specific LCDs on neurological diagnostic procedures. Yet most generalist vendors handle them with the same reactive appeals process they use for every other specialty.
The result is compounding payer variance across high-volume payer categories. Generic billing vendors absorb this variance as routine write-offs. By contrast, MBC’s Revenue Integrity Framework is built specifically to eliminate it.
The Triple Threat to Texas Neurology Group Margins:
1. Novitas LCD Non-Compliance on Neurodiagnostic Procedures
EEG (CPT 95816, 95819, 95827), EMG (CPT 95860–95864), and nerve conduction studies (CPT 95907–95913) are among Novitas’s most actively enforced LCD categories. Practices that submit without a pre-authorization documentation review see average denial rates of 11%–15% on these procedures. Consequently, for groups performing 200+ neurodiagnostic studies per month, that means $110,000–$180,000 in annual revenue leakage.
2. Infusion Therapy Undercoding and Prior Authorization Failures
MS biologic infusion billing covers natalizumab (J2323), ocrelizumab (J2350), and ofatumumab (J3061). Each requires precise HCPCS coding for dosing units, site-of-service modifiers, and prior authorization compliance. However, generic RCM vendors cannot reliably deliver this precision. In addition, dosing unit miscounts and missing modifiers alone cost practices with active infusion suites $85,000–$140,000 every 12 months.
3. High-Complexity E/M Downcoding Under MDM Documentation Rules
The 2021 AMA E/M MDM revision removed time-based coding shortcuts. However, many Texas neurology practices had relied on those shortcuts for 99215 capture. Without updated documentation protocols, practices are routinely downcoded from 99215 to 99214. That is a $48–$62 loss per visit. Over 12 months, it adds up to $290,000–$470,000 for a high-volume neurology group. According to CMS E/M guidelines, the CPT E/M rules for MDM apply to all office/outpatient visits. Therefore, proactive documentation audits are essential for high-volume neurology practices.
2026 Updates Affecting Texas Neurology Billing
Several rule changes in 2026 raise the stakes for Texas neurology practices. As a result, a specialty billing partner is more valuable than ever:
- CMS WISeR Model (Texas is a participating state): The Wasteful and Inappropriate Service Reduction Model started on January 1, 2026. It adds prior authorization or pre-payment review for selected Original Medicare services in Texas and five other states. For example, nerve stimulator implants and deep brain stimulation can be affected. So, authorization tracking now goes beyond Medicare Advantage.
- CMS Interoperability and Prior Authorization Rule (CMS-0057-F): Starting in 2026, Medicare Advantage and Medicaid managed care plans must decide on prior authorization requests faster. Urgent requests need a decision within 72 hours, and standard requests within 7 calendar days. Plans must also give a specific reason for each denial. Therefore, practices that send complete records the first time benefit most.
- 2026 Medicare Physician Fee Schedule: CMS applied an efficiency adjustment to non-time-based services, including many neurodiagnostic tests. However, time-based E/M visits were not reduced. As a result, accurate E/M MDM notes and correct diagnostic coding matter even more.
- Texas gold carding (HB 3459): Texas doctors who meet approval thresholds with state-regulated plans can skip certain prior authorization requests. In other words, a clean authorization history becomes a real business asset.
MBC tracks these changes for every Texas neurology client. Then, it updates authorization, documentation, and coding workflows before they cause denials.
Neurology Billing Complexity in Texas: Generic RCM vs. MBC
| Revenue Challenge | Generic RCM | MBC Texas Neurology |
|---|---|---|
| Novitas LCD Compliance | Reactive post-denial appeals | Pre-submission Novitas-specific documentation protocols |
| TX Medicaid STAR/STAR+PLUS | Standard submission | STAR MCO-specific neurology billing + contract analytics |
| Infusion Therapy (MS Biologics) | Basic J-code submission | Real-time HCPCS integration + dosing unit verification |
| MA Diagnostic Interpretation Review | Manual appeals | NLP-resistant documentation + algorithmic denial defense |
| E/M MDM Documentation | Periodic audits | Provider-specific MDM coaching + pre-submission review |
| Net Collection Ratio | 85%–91% | 93%–97% |
| Denial Rate | 11%–15% | 3%–5% |
| Days in AR | 42–58 days | 18–24 days |
MBC Spotlight: Texas Neurology Revenue Integrity in Practice
MBC’s neurology billing services in Texas use a denial root-cause engineering model. In other words, MBC is not a claims clearinghouse. Specifically, every Texas neurology engagement begins with a Complimentary 90-Day AR Diagnostic. First, it maps your current denials by payer, procedure category, and provider. Next, it measures your recoverable leakage against specialty benchmarks. Finally, it builds a payer variance detection protocol tuned to your Novitas MAC jurisdiction and Texas commercial payer mix.
What the 90-Day AR Diagnostic delivers for Texas neurology groups:
- Novitas LCD gap analysis across EEG, EMG, NCS, and autonomic function testing
- E/M MDM documentation scoring by provider with 99215 capture rate benchmarking
- MS biologic infusion coding audit — HCPCS accuracy, dosing units, prior authorization compliance
- Texas STAR/STAR+PLUS managed care authorization gap identification
- AR Aging stratification by payer with 30% A/R reduction within 90 days recovery pathway
Proven Results for Texas Neurology Groups
Texas neurology clients recover an average of $145,000 in diagnostic and infusion revenue within 90 days. In addition, Novitas LCD compliance cuts EEG and EMG denial rates from 14% to under 4%.
MBC’s system-agnostic platform works with your existing EHR, including Epic, Athenahealth, NextGen, and eClinicalWorks. Because of this, no migration is required. Meanwhile, your dedicated account manager keeps provider-level visibility into net realized revenue growth across every payer category.
MBC’s 25+ years of specialty revenue cycle experience and 97% clean claim rate are not averages across general medicine. Instead, they reflect results in high-complexity specialty billing. In these settings, documentation precision and payer-specific compliance decide whether a claim pays or posts as a denial.
How MBC Compares to Large RCM Companies
Major neurology billing companies in Texas include Navicure, R1 RCM, Ensemble Health Partners, and Guidehouse. All of them are enterprise RCM organizations that apply general workflows to specialty billing. Admittedly, their scale produces volume throughput. However, it does not produce Novitas LCD expertise, Texas STAR managed care precision, or infusion therapy HCPCS accuracy at the provider level. Finally, MBC’s fee structure is percentage-of-collections with no upfront cost. In short, you pay when collections improve, not before.
Request Your Free Revenue Diagnostic
Texas neurology groups collecting $1M to $5M or more per month lose $400,000–$900,000 in preventable revenue every 12 months. This is not due to coding volume. Instead, it comes from Novitas LCD non-compliance, infusion undercoding, and MA diagnostic denials. Generic billing workflows simply treat these losses as acceptable attrition.
MBC’s Strategic Revenue Diagnostic shows exactly where your neurology revenue is leaking before you make any commitment. Then, your dedicated account manager delivers a payer-specific recovery roadmap at no cost. It is quantified, actionable, and tuned to your Texas MAC jurisdiction.
Request Your Free Revenue Diagnostic
Related Neurology Billing Resources
- What Is Causing Neurology Claim Denials — Understand the most common denial triggers in neurology billing and how to address them proactively.
- Reduce Denials and Delays in Neurology Billing — Proven strategies to improve clean claim rates and reduce days in AR for neurology practices.
- Best Neurology Billing Companies 2026 — Compare the top neurology billing partners for E/M revenue management and denial reduction.
- Mastering Neurology Billing Guidelines — A complete guide to neurology billing codes, documentation requirements, and payer rules.
- Neurology Billing Services in California — See how MBC’s specialty neurology billing expertise extends to California practices and payer environments.
Frequently Asked Questions
1. What makes a neurology billing partner in Texas different from a general medical billing service?
A Texas neurology billing partner must deliver three key capabilities. These are Novitas LCD-compliant neurodiagnostic coding, precise MS biologic infusion billing, and high-complexity E/M MDM documentation protocols. In contrast, generalist billing services in Texas often see 11%–15% denial rates on these high-dollar procedures.
2. What Novitas MAC LCD policies most affect Texas neurology billing?
Novitas enforces active LCDs on EEG (L34795), EMG, nerve conduction studies, and autonomic function testing. Each one requires medical necessity documentation before submission, not appeals after denial. This matters because the average Novitas appeal cycle recovers less than 60% of denied neurodiagnostic revenue. You can review active CMS Local Coverage Determinations for current Novitas LCD policies.
3. How does Texas STAR Medicaid affect neurology specialist reimbursement?
Texas STAR and STAR+PLUS MCOs apply their own prior authorization rules. Without dedicated MCO follow-up, practices are paid 12%–18% below contracted rates. As a result, groups without payer variance detection face AR Aging cycles of 50–80 days.
4. What infusion therapy billing errors are most common in Texas neurology practices?
The most common error is choosing the wrong HCPCS J-code for MS biologics such as natalizumab (J2323), ocrelizumab (J2350), and ofatumumab (J3061). In addition, dosing unit miscounts and missing site-of-service modifiers add to the problem. Together, these errors average $85,000–$140,000 in revenue leakage every 12 months for active Texas neurology infusion suites.
5. Does MBC handle Medicare Advantage neurology billing for Texas groups?
Yes. MBC manages Texas Medicare Advantage neurology billing across all major MA plans in Houston, Dallas-Fort Worth, San Antonio, and Austin. It uses NLP-resistant documentation protocols and diagnostic interpretation appeal workflows. As a result, MBC recovers 78%–84% of initially denied MA claims within 30 days.
6. Does the CMS WISeR Model affect neurology practices in Texas?
Yes. Texas is one of six states in the WISeR Model, which began on January 1, 2026. The model adds prior authorization or pre-payment review for selected Original Medicare services. Therefore, neurology groups that perform procedures such as nerve stimulator implants or deep brain stimulation should confirm requirements before scheduling.
7. How do the 2026 prior authorization rules change Medicare Advantage neurology billing?
Under CMS-0057-F, Medicare Advantage and Medicaid managed care plans must decide on prior authorization requests within 72 hours for urgent cases. For standard requests, the limit is 7 calendar days. Plans must also give a specific denial reason. As a result, practices that submit complete records can correct and resubmit faster.
8. How quickly can a Texas neurology practice see results after switching to MBC?
Most engagements start with a Complimentary 90-Day AR Diagnostic. On average, Texas neurology clients recover $145,000 in diagnostic and infusion revenue within 90 days. In addition, EEG and EMG denial rates fall from about 14% to under 4%.
Neurology Billing Services in Texas: Accurate Coding, Faster Payments, Better Cash Flow
Phone: 888-357-3226Fax: 888-316-4566
Email: sales@medicalbillersandcoders.com

A Subject Matter Expert in healthcare billing operations with nearly 10 years of experience, sharing insights on claims processing, coding support, and revenue cycle optimization. Dedicated to educating healthcare professionals on compliance, accuracy, and strategies to improve billing performance.